Research and Markets has announced the addition of the "Anesthetic Effect - Pipeline Review, H2 2016" report to their offering.
'Anesthetic Effect - Pipeline Review, H2 2016'; Anesthetic Effect pipeline therapeutics constitutes close to 23 molecules. Out of which approximately 22 molecules are developed by Companies and remaining by the Universities
Institutes.
Anesthetic Effect Anesthetic effect causes a loss of consciousness. The factors that can increase risk of complications include smoking, obstructive sleep apnea, obesity, high blood pressure, history of adverse reactions to anesthesia and drug allergies.
'Anesthetic Effect - Pipeline Review, H2 2016' outlays comprehensive information on the therapeutics under development for Anesthetic Effect, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.
It also reviews of key players involved in therapeutic development for Anesthetic Effect and features dormant and discontinued projects. Currently, The molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 3, 1, 3, 12, 1 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.
Key Topics Covered:
- Introduction
- Anesthetic Effect Overview
- Therapeutics Development
- Pipeline Products for Anesthetic Effect - Overview
- Pipeline Products for Anesthetic Effect - Comparative Analysis
- Anesthetic Effect - Therapeutics under Development by Companies
- Anesthetic Effect - Therapeutics under Investigation by Universities/Institutes
- Anesthetic Effect Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Anesthetic Effect - Products under Development by Companies
- Anesthetic Effect - Products under Investigation by Universities/Institutes
- Anesthetic Effect - Companies Involved in Therapeutics Development
- Biolab Farmaceutica Ltda
- Drawbridge Pharmaceuticals Pty Ltd
- Expanesthetics Inc
- Jiangsu Hengrui Medicine Co., Ltd.
- Lipicard Technologies Limited
- NanoMedex Pharmaceuticals, Inc.
- Paion AG
- Phosphagenics Limited
- Physica Pharma
- Primex Pharmaceuticals Oy
- Proteus SA
- Sphaera Pharma Pvt. Ltd.
- Taiwan Liposome Company, Ltd.
- The Medicines Company
For more information about this report visit http://www.researchandmarkets.com/research/lrn5sg/anesthetic_effect
View source version on businesswire.com: http://www.businesswire.com/news/home/20161028005514/en/
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related
Topics: Anesthetic
Drugs